Details of the Drug
General Information of Drug (ID: DMO6XK2)
Drug Name |
4-nitrophenylboronic acid
|
||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Synonyms |
4-Nitrophenylboronic acid; 24067-17-2; (4-nitrophenyl)boronic Acid; 4-Nitrobenzeneboronic acid; p-nitrophenylboronic acid; 4-Nitrophenyl boronic acid; p-nitrophenyl boronic acid; 4-Nitro phenyl boronic acid; Boronic acid, (4-nitrophenyl)-; MFCD00161360; 4-Nitrophenylboronic acid, 97%; 4-Nitrophenylboronicacid; 4-Borononitrobenzene; PubChem24079; 4-nitrobenzenboronic acid; (4-nitrophenyl)boranediol; 4-nitro-phenylboronic acid; ACMC-209g8k; para-nitrophenylboronic acid; 4-nitrobenzene boronic acid; AC1MCN49; SCHEMBL5993
|
||||||||||||||||||||||
Indication |
|
||||||||||||||||||||||
Drug Type |
Small molecular drug
|
||||||||||||||||||||||
Structure | |||||||||||||||||||||||
3D MOL | 2D MOL | ||||||||||||||||||||||
#Ro5 Violations (Lipinski): 0 |
Molecular Weight | 166.93 | |||||||||||||||||||||
Logarithm of the Partition Coefficient | Not Available | ||||||||||||||||||||||
Rotatable Bond Count | 1 | ||||||||||||||||||||||
Hydrogen Bond Donor Count | 2 | ||||||||||||||||||||||
Hydrogen Bond Acceptor Count | 4 | ||||||||||||||||||||||
Chemical Identifiers |
|
||||||||||||||||||||||
Cross-matching ID | |||||||||||||||||||||||
Molecular Interaction Atlas of This Drug
Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Molecular Interaction Atlas (MIA) | |||||||||||||||||||||||||||
Molecular Expression Atlas of This Drug
The Studied Disease | Discovery agent | |||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ICD Disease Classification | N.A. | |||||||||||||||||||||||
|
||||||||||||||||||||||||
Molecular Expression Atlas (MEA) | ||||||||||||||||||||||||